U.S sterile injectables market is estimated to be valued at US$ 131.8 billion in 2022 and expected to exhibit a CAGR of 9.3% over the forecast period 2022-2030 ...

Barclays cuts Prudential price target to 1,250 (1,380) pence - 'overweight' Barclays reinitiates Barratt Developments with 'overweight' - price target 641 pence Barclays raises HGCapital Trust to ...

Hikma is offering clindamycin in 5% dextrose injection, in 300mg/50ml, 600mg/50ml and 900mg/50ml doses. The product is available in a vial. Clindamycin in 5% dextrose injection is indicated for ...

SHANGHAI, Sept 3 (Reuters) - Tesla (TSLA.O), opens new tab plans to produce a six-seat variant of its Model Y car in China from late 2025, two people with direct knowledge of the matter said ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.45% to £19.74 Monday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.15 ...

Wells Fargo analyst Yanan Zhu assigned a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) on August 30 and set a price target of $82.00. Yanan Zhu’s rating is based on a ...

The Fama and French Three-Factor Model (or the Fama French Model for short) is an asset pricing model developed in 1992 that expands on the capital asset pricing model (CAPM) by adding size risk ...

Alibaba Cloud, the cloud computing arm of China’s Alibaba Group Ltd., announced Thursday the release of a new artificial intelligence model named Qwen2-VL capable of advanced vision ...

Hikma Pharmaceuticals PLC HIK shares inched down 0.50% to £19.83 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0.04% ...